文献速递MDS 与骨髓增殖性肿瘤造血干细胞移植与细胞治疗

骨髓增殖性肿瘤对骨稳态的影响:巨核细胞的作用

Myeloproliferative disorders and their effects on bone homeostasis: the role of megakaryocytes.
PubMed 文献 · Blood · 2022-01-01

本文综述了不同形式骨髓增殖性肿瘤(MPN)对骨健康的影响。小鼠模型和人数据表明,PMF患者骨量通常增加,ET或PV患者骨量轻度减少或无改变;PMF骨硬化可致骨髓衰竭,ET/PV骨丢失可致骨质疏松性骨折。部分MPN与巨核细胞增多相关,巨核细胞相关因子影响骨发育。

要点

  • PMF患者骨量通常增加,骨硬化可导致骨髓衰竭。
  • ET或PV患者骨量轻度减少或无改变,骨丢失可致骨质疏松性骨折。
  • 部分MPN中巨核细胞增多,其分泌因子影响骨发育。

核心结论

  • 不同形式MPN对骨密度及成骨细胞增殖分化有不同程度影响,骨健康变化与巨核细胞及分泌因子相关。

研究设计与样本

  • 综述,基于小鼠模型和人类数据,聚焦MPN对骨健康的影响及巨核细胞作用。

主要发现

  • PMF患者骨量通常增加,ET或PV患者骨量轻度减少或无改变。
  • PMF骨硬化是严重并发症,可导致骨髓衰竭。
  • ET或PV患者骨丢失可导致骨质疏松性骨折。
  • 部分MPN形式与巨核细胞数量增加相关,巨核细胞相关因子影响骨发育。

临床怎么用

  • 理解MPN相关骨健康变化有助于早期干预和治疗该病理副作用。

局限性

  • 多数MPN形式中男女性表型差异未充分探索。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Myeloproliferative neoplasms (MPNs) are a heterogeneous group of chronic hematological diseases that arise from the clonal expansion of abnormal hematopoietic stem cells, of which polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF) have been extensively reviewed in the context of control of clonal expansion, fibrosis, and other phenotypes. Herein, we review current knowledge on the influence of different forms of MPN on bone health. In studies, murine models and human data have implicated various degrees of effect of different forms of MPN on bone density and on osteoblast proliferation and differentiation. Most results have shown that bone volume is generally increased in patients with PMF, whereas it is slightly decreased or not altered in patients with ET or PV, although possible differences between male and female phenotypes were not fully explored in most MPN forms. Osteosclerosis in patients with PMF is a serious complication that can lead to bone marrow failure, and the loss of bone reported in some patients with ET or PV can lead to osteoporotic fractures. Some MPN forms are associated with an increased number of megakaryocytes (MKs), and several of the MK-associated factors in MPN are known to affect bone development. We review known mechanisms involved in these processes, with a focus on the role of MKs and secreted factors. Understanding MPN-associated changes in bone health could improve early intervention and treatment of this side effect of the pathology.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Karagianni A, Ravid K. Myeloproliferative disorders and their effects on bone homeostasis: the role of megakaryocytes. Blood. 2022. PMID: 34428274. doi:10.1182/blood.2021011480

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。